Davita Healthcare Partners Inc
(DVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,211,762 | 962,330 | 642,576 | 291,545 | 994,677 |
| Depreciation Amortization | 680,615 | 505,852 | 335,390 | 165,701 | 630,435 |
| Income taxes - deferred | 60,483 | 56,724 | 40,685 | 18,688 | 240,848 |
| Accounts receivable | -138,140 | -205,792 | -117,171 | -224,274 | -21,087 |
| Accounts payable and accrued liabilities | -30,320 | -47,412 | -47,390 | -75,504 | 37,200 |
| Other Working Capital | -140,639 | -211,547 | -234,842 | -346,280 | -104,172 |
| Other Operating Activity | 287,115 | 340,833 | 214,788 | 324,428 | 201,127 |
| Operating Cash Flow | $1,930,876 | $1,400,988 | $834,036 | $154,304 | $1,979,028 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,957 | 9,367 | 9,744 | 15,449 | 246 |
| PPE Investments | -641,465 | -405,331 | -264,664 | -128,576 | -624,402 |
| Net Acquisitions | -187,050 | -45,143 | -23,890 | -3,668 | -182,013 |
| Purchase Of Investment | -13,924 | -7,925 | -6,029 | -8,549 | -22,341 |
| Purchase Sale Intangibles | 61,464 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 63,663 | 847 | 1,140 | 978 | 3,139 |
| Investing Cash Flow | $-784,733 | $-448,185 | $-283,699 | $-124,366 | $-825,371 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,615,370 | 1,613,036 | 1,611,086 | 1,606,969 | 4,046,775 |
| Debt Repayment | -861,115 | -812,659 | -754,407 | -698,298 | -4,110,304 |
| Common Stock Issued | -60,001 | -59,849 | -43,605 | -2,524 | -975 |
| Common Stock Repurchased | -1,538,626 | -882,411 | -560,507 | -316,250 | -1,458,442 |
| Other Financing Activity | -238,594 | -166,720 | -97,019 | -52,619 | -323,831 |
| Financing Cash Flow | $-1,082,966 | $-308,603 | $155,548 | $537,278 | $-1,846,777 |
| Exchange Rate Effect | -10,007 | -7,381 | -1,197 | -7,966 | -13,808 |
| Beginning Cash Position | 501,790 | 501,790 | 501,790 | 501,790 | 1,208,718 |
| End Cash Position | 554,960 | 1,138,609 | 1,206,478 | 1,061,040 | 501,790 |
| Net Cash Flow | $53,170 | $636,819 | $704,688 | $559,250 | $-706,928 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,930,876 | 1,400,988 | 834,036 | 154,304 | 1,979,028 |
| Capital Expenditure | -641,465 | -451,909 | -294,438 | -144,913 | -674,541 |
| Free Cash Flow | 1,289,411 | 949,079 | 539,598 | 9,391 | 1,304,487 |